癌症（英文版）2016，Vol.35Issue(12)：641-644,4.DOI:10.1186/s40880-016-0162-7
Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma
Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma
Elizabeth A.Kuczynski 1Robert S.Kerbel1
作者信息
- 1. Sunnybrook Research Institute, 2075 Bayview Avenue, S-Wing, Room S217, Toronto, 0N M4N 3M5, Canada
- 折叠
摘要
关键词
Vessel co-option/Non-angiogenic/Resistance/Sorafenib/Hepatocellular carcinomaKey words
Vessel co-option/Non-angiogenic/Resistance/Sorafenib/Hepatocellular carcinoma引用本文复制引用
Elizabeth A.Kuczynski,Robert S.Kerbel..Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma[J].癌症（英文版）,2016,35(12):641-644,4.
